Filing Details
- Accession Number:
- 0001415889-24-021869
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-21 18:38:07
- Reporting Period:
- 2024-08-19
- Accepted Time:
- 2024-08-21 18:38:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1662774 | Quince Therapeutics Inc. | QNCX | Biological Products, (No Disgnostic Substances) (2836) | 901024039 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1929422 | Brendan Hannah | C/O Quince Therapeutics, Inc. 611 Gateway Blvd, Suite 273 South San Francisco CA 94080 | Chief Business Officer And Coo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-08-19 | 2,155 | $0.58 | 259,771 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-08-20 | 2,500 | $0.61 | 262,271 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-08-20 | 3,424 | $0.60 | 265,695 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-08-21 | 2,280 | $0.61 | 267,975 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-08-21 | 5,000 | $0.62 | 272,975 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-08-21 | 23,565 | $0.63 | 296,540 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
